Sens-Vue
- The company was founded in 2022.
- The Danish Patent and Trade Office approved our patent utility model in 2022.
- Running grants and soft-funding projects in Denmark and the UK.
- We welcome talents, partners, and investors with a passion in eye health to join our exciting journey.
Team
Hong de Beer-Song
CEO
Precision Medical Devices
Business Development
Multinational Global Operations
University of Oxford
Michael Regnarsen
CTO
System Architecture
Software
Leading roles in IT companies
Copenhagen Business School
Other Core Members
Dr. Joline Bian
PhD Cand AI Ophthalmology
Dr. Koen Vermeer
PhD, AI Medical Imaging
Dr. Hans G Lemij
PhD, Specialist Glaucoma
Aiax Faura Vilalta
Engineer, DTU
Farkas Attila Jakab
Engineer, DTU
Bent Rønde Jacobsen
CCO
Ion Marqvardsen
VP Product Engineering
Why Choose Sens-Vue
Fast
We provide instant results to screen eye diseases. Our platform can also facilitate manual evaluation with remote specialists.
Reliable
Our algorithm is highly accurate trained on a large patient base of diversity of ethnics. All communication is highly encrypted.
User-friendly
Our products are designed for clinicians as well as non-clinicians, without the need of lengthy trainings.
Partners
